Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation [3]

Medical and Pediatric Oncology

Volumn 41, Issue 5, 2003, Pages 494-495

  Klopfenstein, Kathryn J ^a,b   Rosselet, Robin ^a   Termuhlen, Amanda ^a   Powell, Dwight ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUCYTOSINE; ITRACONAZOLE; MICONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CAPILLARY RESISTANCE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FUNGUS CULTURE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; LETTER; LUNG BIOPSY; PNEUMONIA; PRIORITY JOURNAL; SCEDOSPORIUM; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MADUROMYCOSIS; OPPORTUNISTIC INFECTIONS; PYRIMIDINES; RISK ASSESSMENT; SCEDOSPORIUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIAZOLES;

EID: 0141994964     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10363     Document Type: Letter

References (9)

1. Strickland LB, Greene JN, Sandin RL, et al. Scedosporium species infections in cancer patients: Three cases and review of the literature. Infect Dis in Clin Pract 1998;7:4-11.
2. Guyotat D, Piens MA, Bouvier R, et al. A case of disseminated Scedosporium apiospermum infection after bone marrow transplantation. Mykosen 1987;30:151-154.
3. Walsh TJ, Peter J, McGough DA, et al. Activities of amphotericin B and ntifungal azoles alone and in combination against Pseudallescheria boydii. Antimicrob Agents Chemother 1995;39:1361-1364.
4. Gumbart CH. Pseudallescheria boydii infection after bone marrow transplantation. Ann Intern Med 1983;99:193-194.
5. Goldberg SL, Geha DJ, Marshall WF, et al. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis 1993;16:803-805.
6. Nomdedéu J, Brunet S, Martino R, et al. Successful treatment of pneumonia due to Scedosporium apiospennum with Itraconazole: Case Report. Clin Infect Dis 1993;16:731-733.
7. Girmenia C, Luzi G, Monaco M, et al. Use of voriconazole in treatment of Scedosporium apiospermum infection: Case Report. J Clin Microbiol 1998;36:1436-1438.
8. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of Voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less common mold pathogens. Antimicrob Agents Chemother 1997;41:841-843.
9. Chiou CC, Groll AH, Walsh TJ. New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 2000;5:120-135.